PT  - JOURNAL ARTICLE
AU  - Rasigade, Jean-Philippe
AU  - Barray, Anaïs
AU  - Shapiro, Julie Teresa
AU  - Coquisart, Charlène
AU  - Vigouroux, Yoann
AU  - Bal, Antonin
AU  - Destras, Grégory
AU  - Vanhems, Philippe
AU  - Lina, Bruno
AU  - Josset, Laurence
AU  - Wirth, Thierry
TI  - SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions
AID  - 10.1101/2020.08.24.20180927
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.24.20180927
4099  - http://medrxiv.org/content/early/2020/08/26/2020.08.24.20180927.short
4100  - http://medrxiv.org/content/early/2020/08/26/2020.08.24.20180927.full
AB  - Quantifying the effectiveness of large-scale non-pharmaceutical interventions against COVID-19 is critical to adapting responses against future waves of the pandemic. By combining phylogenetic data of 5,198 SARS-CoV-2 genomes with the chronology of non-pharmaceutical interventions in 57 countries, we examine how interventions and combinations thereof alter the divergence rate of viral lineages, which is directly related to the epidemic reproduction number. Home containment and education lockdown had the largest independent impacts and were predicted to reduce the reproduction number by 35% and 26%, respectively. However, we find that in contexts with a reproduction number >2, no individual intervention is sufficient to stop the epidemic and increasingly stringent intervention combinations may be required. Our phylodynamic approach can complement epidemiological models to inform public health strategies against COVID-19.Competing Interest StatementBL is currently active in groups advising the French government for which BL is not receiving payment.Funding StatementJPR received support from the FINOVI Foundation (grant R18037CC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBoth data and analysis code are available online at https://github.com/rasigadelab/covid-npi. https://github.com/rasigadelab/covid-npi